FiercePharma2d
With amped up manufacturing effort, Sanofi and AZ look to avoid Beyfortus shortfalls this year
As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...
Zacks.com on MSN12h
Sanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?
Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock ...
BioPharma Dive3d
Sanofi readies to meet US demand for RSV antibody
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
Stockhouse4d
Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA
Company planning for every eligible baby in the US to have access to BEYFORTUS New BEYFORTUS filling line approved by the U.S. Food and Drug Administration (FDA) to expand manufacturing capacity ...
Becker's Hospital Review3d
FDA approves manufacturing line for RSV therapy
Sanofi received FDA approval for a new manufacturing line to expand production of Beyfortus, a preventive therapy for respiratory syncytial virus in infants. Beyfortus is the first long-acting ...
Burlington Post2d
Ontario expands vaccination program for ‘highly contagious virus’ that targets respiratory tract
The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...
Yahoo Finance3d
Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA
Company planning for every eligible baby in the US to have access to BEYFORTUS New BEYFORTUS filling line approved by the U.S. Food and Drug Administration (FDA) to expand manufacturing capacity ...